These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 24331761)

  • 1. Addiction science advocacy: mobilizing political support to influence public policy.
    Polcin DL
    Int J Drug Policy; 2014 Mar; 25(2):329-31. PubMed ID: 24331761
    [No Abstract]   [Full Text] [Related]  

  • 2. From Private Practice to Academia: Integrating social and political advocacy into every MFT Identity.
    Goodman JM; Morgan AA; Hodgson JL; Caldwell BE
    J Marital Fam Ther; 2018 Jan; 44(1):32-45. PubMed ID: 29194692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug policing, harm reduction and health: directions for advocacy.
    Burris S; Burrows D
    Int J Drug Policy; 2009 Jul; 20(4):293-5. PubMed ID: 19403297
    [No Abstract]   [Full Text] [Related]  

  • 4. Public roles of US physicians: community participation, political involvement, and collective advocacy.
    Gruen RL; Campbell EG; Blumenthal D
    JAMA; 2006 Nov; 296(20):2467-75. PubMed ID: 17119143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Practice-based teaching for health policy action and advocacy.
    Hearne SA
    Public Health Rep; 2008; 123 Suppl 2(Suppl 2):65-70. PubMed ID: 18770919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interprofessional Education: Reaching Health Professionals With an Interactive Professional Virtual/Online Event on Advocacy and Policy.
    Liller KD; Pruitt Z; Burke SG
    Front Public Health; 2020; 8():606394. PubMed ID: 33344406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The health educator's role in advocacy and policy: principles, processes, programs, and partnerships.
    Caira NM; Lachenmayr S; Sheinfeld J; Goodhart FW; Cancialosi L; Lewis C
    Health Promot Pract; 2003 Jul; 4(3):303-13. PubMed ID: 14611001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mobilizing Drug Consumption Rooms: inter-place networks and harm reduction drug policy.
    McCann E; Temenos C
    Health Place; 2015 Jan; 31():216-23. PubMed ID: 25576837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Report of the 2010-2011 Standing Committee on Advocacy: Leveraging faculty engagement to improve public policy.
    Coffman RE; Bratberg JP; Flowers SK; Murphy NL; Nemire RE; Anderson LJ; Lang WG
    Am J Pharm Educ; 2011 Dec; 75(10):S7. PubMed ID: 22345754
    [No Abstract]   [Full Text] [Related]  

  • 10. Community psychology and transformative policy change in the neo-liberal era.
    Nelson G
    Am J Community Psychol; 2013 Dec; 52(3-4):211-23. PubMed ID: 23877840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advocacy and Public Policy Perceptions and Involvement of Master Certified Health Education Specialists.
    Kerr DL; Van Wasshenova E; Mahas R; Everhart FJ; Thompson A; Boardley D
    Health Promot Pract; 2017 Sep; 18(5):706-714. PubMed ID: 28812931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Addressing drug abuse: policy deliberations in the great south land.
    Samet JH
    Public Health Rep; 2000; 115(5):476-9. PubMed ID: 11236020
    [No Abstract]   [Full Text] [Related]  

  • 13. Federalism and social justice: implications for social work.
    Linhorst DM
    Soc Work; 2002 Jul; 47(3):201-8. PubMed ID: 12194400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Century of Political Influence: The Evolution of the Canadian Nurses Association's Policy Advocacy Agenda.
    Chiu P; Villeneuve MJ; Paul P
    Can J Nurs Res; 2020 Sep; 52(3):176-184. PubMed ID: 32893691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Political science, public policy, and drug use prevention.
    Pentz MA; Mares D; Schinke S; Rohrbach LA
    Subst Use Misuse; 2004; 39(10-12):1821-65. PubMed ID: 15587952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Illicit drug addiction, infectious disease spread, and the need for an evidence-based response.
    Wood E; Montaner JS; Kerr T
    Lancet Infect Dis; 2008 Mar; 8(3):142-3. PubMed ID: 18291331
    [No Abstract]   [Full Text] [Related]  

  • 17. Putting at risk what we know: reflecting on the drug-using subject in harm reduction and its political implications.
    Moore D; Fraser S
    Soc Sci Med; 2006 Jun; 62(12):3035-47. PubMed ID: 16413645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Innovation in social policy: collaborative policy advocacy.
    Sherraden MS; Slosar B; Sherraden M
    Soc Work; 2002 Jul; 47(3):209-21. PubMed ID: 12194401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of state attorneys general in health policy.
    Rutkow L; Teret SP
    JAMA; 2010 Sep; 304(12):1377-8. PubMed ID: 20858882
    [No Abstract]   [Full Text] [Related]  

  • 20. Public health and media advocacy.
    Dorfman L; Krasnow ID
    Annu Rev Public Health; 2014; 35():293-306. PubMed ID: 24328989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.